Opens in a new tab

40-Year-Old MENA Pharmaceutical Manufacturing Company

40-Year-Old MENA Pharmaceutical Manufacturing Company
Country
JordanJordan
Industry
Pharma
Listing ID
L#20230509
Target Price
$45,000,000
Revenue
$37,000,000
EBITDA
$6,279,944

Description

This Pharmaceutical Manufacturing Company was founded around 40-Year-Old in Amman, Jordan. It holds the regional benchmark in innovation with more than 70 patents.

As direct result of this innovation, operations were diversified outside the traditional generic pharmaceutical industry by spinning out mature technology platforms into subsidiaries with independent management and resources.

Verticals

1. Core branded generic pharmaceutical business.

2. Natural products through the subsidiary.

3. Biotech diagnostics through the subsidiary.

4. Novel excipients and drug delivery systems through the subsidiary.

Products

Products cover a wide range of therapeutic categories including the Cardiovascular, Gastrointestinal, Central Nervous System, Anti- Infective, Endocrine, Musculoskeletal, Respiratory, Obstetric, Gynecology & Urinary Tract, and Immune Systems.

Pharmaceutical Business

It offers more than 200 pharmaceutical products that cover the needs of consumers and healthcare professionals. These products include tablets, capsules, suppositories, syrups and suspensions, which are manufactured in accordance with Good Manufacturing Practices (GMP). The company has a competitive advantage that makes it one of the leading pharmaceutical companies, as its products are of high “Quality”.

Natural Products

It is renowned as the one of the best company in the Middle East specializing in the development and production of plant and herbal medical products from standardized medicinal plant extracts, offering more than 50 natural and herbal innovative products with business operations in more than 20 countries worldwide.

Biotechnology

It is a developer and producer of proprietary biotechnology healthcare products that specializes in the production.

Basic Details

Listing ID
L#20230509
Country
Jordan
Industry
Pharma
Deal Status
Available
Target Price
$45,000,000
Revenue
$37,000,000
EBITDA
$6,279,944
Revenue Multiple
1.22x
EBITDA Multiple
7.17x

M&A Middle Market Advisory Deal Tombstones 2024

AdvisorDeals
MergersCorp M&A International21
Keith Advisory17
GCG9
JP Morgan41
Jefferies23
Lazard26
Goldman Sachs30

Businesses for Sale

Similar Opportunities